More recently, using molecular (over-expression of the inhibitor Smad, Smad7) and pharmacological (SD-208 and/or halofuginone) approaches, we clearly demonstrated that TGF-βs affect osteosarcoma tumor growth and lung metastatic development [38,89]. The gene discussed is SMAD7; the disease is osteosarcoma.